Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAston Martin Lagonda Regulatory News (AML)

Share Price Information for Aston Martin Lagonda (AML)

Share Price is delayed by 15 minutes
Get Live Data
41.54    0.74 (1.81%)
Bid:
41.20
Ask:
41.44
Spread: 0.24 (0.583%)
Market Cap: £420.67m
AML Live PriceLast checked at - London Stock Exchange

Intraday Aston Martin Lagonda Share Chart

Holding(s) in Company

30 Sep 2022 15:59

RNS Number : 4142B
Aston Martin Lagonda Glob.Hldgs PLC
30 September 2022
 

TR-1: Standard form for notification of major holdings

1. Issuer Details

ISIN

GB00BN7CG237

Issuer Name

ASTON MARTIN LAGONDA GLOBAL HOLDINGS PLC

UK or Non-UK Issuer

UK

2. Reason for Notification

An acquisition or disposal of voting rights

3. Details of person subject to the notification obligation

Name

Lawrence Stroll

City of registered office (if applicable)

Gaydon

Country of registered office (if applicable)

United Kingdom

4. Details of the shareholder

Name

City of registered office

Country of registered office

Securities Services Nominees Limited

London

United Kingdom

5. Date on which the threshold was crossed or reached

28-Sep-2022

6. Date on which Issuer notified

30-Sep-2022

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8.A)

% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuer

Resulting situation on the date on which threshold was crossed or reached

19.028622

0.000000

19.028622

132963844

Position of previous notification (if applicable)

18.304412

0.000000

18.304412

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

8A. Voting rights attached to shares

Class/Type of shares ISIN code(if possible)

Number of direct voting rights (DTR5.1)

Number of indirect voting rights (DTR5.2.1)

% of direct voting rights (DTR5.1)

% of indirect voting rights (DTR5.2.1)

GB00BN7CG237

0

132963844

0.000000

19.028622

Sub Total 8.A

132963844

19.028622%

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

Type of financial instrument

Expiration date

Exercise/conversion period

Number of voting rights that may be acquired if the instrument is exercised/converted

% of voting rights

 

Sub Total 8.B1

8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

Type of financial instrument

Expiration date

Exercise/conversion period

Physical or cash settlement

Number of voting rights

% of voting rights

 

Sub Total 8.B2

9. Information in relation to the person subject to the notification obligation

2. Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entities (please add additional rows as necessary)

Ultimate controlling person

Name of controlled undertaking

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

Lawrence Stroll

MSM Trust Corporation as trustee of The Wellington Trust

14.737696

0.000000

14.737696%

Lawrence Stroll

Flair Investment Holdings Limited

14.737696

0.000000

14.737696%

Lawrence Stroll

Elevage Limited

14.737696

0.000000

14.737696%

Lawrence Stroll

Yew Tree Overseas Limited

14.737696

0.000000

14.737696%

Lawrence Stroll

Securities Services Nominees Limited

16.225554

0.000000

16.225554%

10. In case of proxy voting

Name of the proxy holder

 

The number and % of voting rights held

 

The date until which the voting rights will be held

 

11. Additional Information

Immediately following the rights issue of ordinary shares by Aston Martin Lagonda Global Holdings plc (the "Company") on 28 September 2022 (the "Rights Issue"), Lawrence Stroll indirectly controlled the voting rights of 128,103,375 ordinary shares of the Company, corresponding to 18.333034% of the Company's issued share capital.Following the rights issue, Yew Tree Overseas Limited ("Yew Tree") and certain Other Consortium Members (as defined below) purchased 4,860,469 ordinary shares in the rump placing and, as a result, Lawrence Stroll indirectly controls the voting rights of 132,963,844 ordinary shares of the Company, and such shares amount to 19.028622% of the Company's issued share capital.Securities Services Nominees Limited holds a number of the Company's shares on the shareholder register as nominee for other shareholders in addition to the shares it holds in its capacity as nominee for Yew Tree, hence the discrepancy between the percentages of voting rights held by Securities Services Nominees Limited and Yew Tree in Box 9 above.The other members of the consortium of the Company's shareholders led by Yew Tree, being Saint James Invest SA, J.C.B. Research, RRRR Investments LLC, FrancInvest Holding Corporation, John Idol, Omega Funds I Limited and ErsteAM Ltd (the "Other Consortium Members") have given personal undertakings to Lawrence Stroll that they will exercise the voting rights attaching to the shares in the Company directly or indirectly held by them in accordance with Lawrence Stroll's instructions. Lawrence Stroll therefore indirectly holds the voting rights attaching to the shares in the Company directly and indirectly held by the Other Consortium Members.

12. Date of Completion

30-Sep-2022

13. Place Of Completion

London, United Kingdom

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLURVSRUVUKOAR
Date   Source Headline
9th Jun 202611:32 amRNSDirector/PDMR Shareholding
4th Jun 20267:00 amRNSIssue of equity to satisfy share awards
15th May 20267:00 amRNSIssue of equity to satisfy employee share awards
6th May 202612:51 pmRNSVoting results of AGM 2026
29th Apr 20267:00 amRNSQ1 results for three months ended 31 March 2026
25th Mar 20269:53 amRNSAnnual Financial Report
9th Mar 202612:12 pmRNSResult of Meeting
25th Feb 20267:00 amRNSPreliminary Results FY2025
20th Feb 20267:00 amRNSNotice of GM and FY 2025 Trading Update
29th Oct 20257:00 amRNSQ3 results for the quarter ended 30 September 2025
6th Oct 20257:00 amRNSQ3 2025 Trading Update and revised outlook
10th Sep 202511:33 amRNSDirector/PDMR Shareholding
5th Sep 20257:00 amRNSIssue of equity to satisfy employee share awards
30th Jul 20257:00 amRNSInterim results
28th Jul 20254:33 pmRNSDirectorate Change
27th May 202510:13 amRNSDirector/PDMR Shareholding
27th May 202510:12 amRNSDirector/PDMR Shareholding
15th May 202510:38 amRNSHolding(s) in Company
13th May 20255:26 pmRNSHolding(s) in Company
13th May 202510:33 amRNSDirector/PDMR Shareholding
13th May 202510:31 amRNSDirector/PDMR Shareholding
13th May 202510:26 amRNSDirector/PDMR Shareholding
12th May 20255:53 pmRNSHolding(s) in Company
12th May 20251:13 pmRNSHolding(s) in Company
12th May 202512:52 pmRNSHolding(s) in Company
7th May 20252:45 pmRNSDirector/PDMR Shareholding
7th May 20251:15 pmRNSResult of General Meeting and issue of equity
7th May 20251:07 pmRNSVoting Result of AGM
30th Apr 20257:00 amRNS1st Quarter Results
17th Apr 20258:57 amRNSNotice of General Meeting
16th Apr 20253:20 pmRNSDirector Declaration
31st Mar 20255:11 pmRNSStatement regarding media comments
31st Mar 20257:00 amRNSProposed investment by Yew Tree Consortium
26th Mar 20259:24 amRNSAnnual Financial Report
26th Feb 20257:00 amRNSPreliminary results year ended 31 December 2024
25th Feb 202510:00 amRNSIndependent Non-executive Director appointment
7th Feb 20255:29 pmRNSHolding(s) in Company
13th Dec 20249:00 amRNSDirectorate Change
4th Dec 20244:00 pmRNSHolding(s) in Company
29th Nov 20244:15 pmRNSHolding(s) in Company
29th Nov 20241:01 pmRNSHolding(s) in Company
29th Nov 202412:46 pmRNSDirector/PDMR Shareholding Replacement
29th Nov 202412:18 pmRNSDirector/PDMR Shareholding
29th Nov 202412:17 pmRNSDirector/PDMR Shareholding
29th Nov 202412:11 pmRNSDirector/PDMR Shareholding
27th Nov 20247:00 amRNSResult of Equity Issue
26th Nov 20245:06 pmRNSIssue of Equity
26th Nov 20244:58 pmRNSIssue of Equity
6th Nov 202410:37 amRNSDirector/PDMR Shareholding
30th Oct 20247:00 amRNS3rd Quarter Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.